TGA approves new severe asthma treatment Exdensur for Australians
A newly registered asthma treatment has been given the green light by the Therapeutic Goods of Australia (TGA),…
SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
Sanofi SNY and partner Regeneron REGN announced that the European Commission has approved Dupixent (dupilumab) for the treatment of…